TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Intelligent Bio Solutions ( (INBS) ) has shared an update.
On October 16, 2025, Intelligent Bio Solutions Inc. held its annual meeting of stockholders, where an amendment to the 2019 Long Term Incentive Plan was approved, increasing the shares available for issuance by 495,000. The meeting also saw the election of directors, ratification of UHY LLP as the accounting firm, and approval of several proposals including a reverse stock split and issuance of shares upon warrant exercise.
The most recent analyst rating on (INBS) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Intelligent Bio Solutions stock, see the INBS Stock Forecast page.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Underperform.
The overall stock score is heavily influenced by the company’s weak financial performance, characterized by consistent losses and negative cash flows. Technical analysis also indicates bearish momentum, further contributing to a low score. The valuation is challenging due to a negative P/E ratio and lack of dividend yield, providing little incentive for investors.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Average Trading Volume: 195,928
Technical Sentiment Signal: Sell
Current Market Cap: $9.8M
For detailed information about INBS stock, go to TipRanks’ Stock Analysis page.